[go: up one dir, main page]

DE60219124D1 - Verfahren und Kit zum Nachweis, oder zum Quantifizieren von, Metaboliten von Fentanyl und Metaboliten von Fentanyl Analoga - Google Patents

Verfahren und Kit zum Nachweis, oder zum Quantifizieren von, Metaboliten von Fentanyl und Metaboliten von Fentanyl Analoga

Info

Publication number
DE60219124D1
DE60219124D1 DE60219124T DE60219124T DE60219124D1 DE 60219124 D1 DE60219124 D1 DE 60219124D1 DE 60219124 T DE60219124 T DE 60219124T DE 60219124 T DE60219124 T DE 60219124T DE 60219124 D1 DE60219124 D1 DE 60219124D1
Authority
DE
Germany
Prior art keywords
metabolites
fentanyl
analogs
quantifying
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60219124T
Other languages
English (en)
Other versions
DE60219124T2 (de
Inventor
Robert Ivan Mcconnell
El Ouard Benchikh
Stephen Peter Fitzgerald
John Victor Lamont
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Randox Laboratories Ltd
Original Assignee
Randox Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Randox Laboratories Ltd filed Critical Randox Laboratories Ltd
Application granted granted Critical
Publication of DE60219124D1 publication Critical patent/DE60219124D1/de
Publication of DE60219124T2 publication Critical patent/DE60219124T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486Analgesics, e.g. opiates, aspirine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2430/00Assays, e.g. immunoassays or enzyme assays, involving synthetic organic compounds as analytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Hydrogenated Pyridines (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
DE60219124T 2001-11-16 2002-11-15 Verfahren und Kit zum Nachweis, oder zum Quantifizieren von, Metaboliten von Fentanyl und Metaboliten von Fentanyl Analoga Expired - Lifetime DE60219124T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01204401 2001-11-16
EP01204401 2001-11-16

Publications (2)

Publication Number Publication Date
DE60219124D1 true DE60219124D1 (de) 2007-05-10
DE60219124T2 DE60219124T2 (de) 2008-01-31

Family

ID=8181257

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60219124T Expired - Lifetime DE60219124T2 (de) 2001-11-16 2002-11-15 Verfahren und Kit zum Nachweis, oder zum Quantifizieren von, Metaboliten von Fentanyl und Metaboliten von Fentanyl Analoga

Country Status (5)

Country Link
US (1) US7109310B2 (de)
CN (1) CN100402084C (de)
AT (1) ATE358275T1 (de)
DE (1) DE60219124T2 (de)
ES (1) ES2284783T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4613299B2 (ja) * 2003-01-30 2011-01-12 ディーエイチ テクノロジーズ デベロップメント プライベート リミテッド 分析物分析に関する方法、混合物、キット、および組成物
US20060040406A1 (en) * 2004-02-17 2006-02-23 David Schneider Narcotic analgesic tracking system
US10512644B2 (en) 2007-03-12 2019-12-24 Inheris Pharmaceuticals, Inc. Oligomer-opioid agonist conjugates
US8173666B2 (en) * 2007-03-12 2012-05-08 Nektar Therapeutics Oligomer-opioid agonist conjugates
CA2734333A1 (en) * 2008-09-16 2010-03-25 Nektar Therapeutics Pegylated opioids with low potential for abuse
ES2523896T3 (es) * 2010-02-02 2014-12-02 Randox Laboratories Ltd. Inmunoensayo de zolpidem con ventana de detección extendida
CN102249986B (zh) * 2011-02-28 2016-06-22 华东理工大学 N-苯乙基-4-苯胺基哌啶的制备方法
GB201313938D0 (en) 2013-08-05 2013-09-18 Randox Lab Ltd Immunoassay for phenethylamines of the 2C and DO sub-families
GB201409516D0 (en) 2014-05-29 2014-07-16 Randox Lab Ltd Immunoassay for compounds of the NBOMe family
BR112018014908A2 (pt) * 2016-01-21 2018-12-18 The Scripps Research Institute vacina de opioide sintético
US11660331B2 (en) 2017-11-09 2023-05-30 The Scripps Research Institute Heroin vaccine
WO2021081063A1 (en) * 2019-10-21 2021-04-29 Veriteque Usa, Inc. Fentanyl analogue detection methods and kits thereof
WO2021092446A1 (en) * 2019-11-08 2021-05-14 Regents Of The University Of Minnesota Fentanyl hapten, fentanyl hapten-conjugates, and methods for making and using
US20230100186A1 (en) * 2020-01-13 2023-03-30 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Fentanyl haptens for the preparation of a fentanyl vaccine
CN111257574B (zh) * 2020-03-04 2024-01-16 中检国研(北京)科技有限公司 用于芬太尼类物质快速筛查的荧光免疫快检卡及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0363041A1 (de) * 1988-09-21 1990-04-11 Ube Industries, Ltd. Monoklonaler Antikörper gegen Morphin, Bereitung von monoklonalen Antikörpern, Testsatz und Verfahren zur Bestimmung von Morphin
EP0832106A2 (de) * 1995-06-05 1998-04-01 Cortech, Inc. Verbindungen mit bradykinin antagonistischen aktivität und mu-opioid agonistischen aktivität
SE9803239D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain

Also Published As

Publication number Publication date
ES2284783T3 (es) 2007-11-16
US7109310B2 (en) 2006-09-19
DE60219124T2 (de) 2008-01-31
CN1428607A (zh) 2003-07-09
ATE358275T1 (de) 2007-04-15
CN100402084C (zh) 2008-07-16
US20030170728A1 (en) 2003-09-11

Similar Documents

Publication Publication Date Title
DE60219124D1 (de) Verfahren und Kit zum Nachweis, oder zum Quantifizieren von, Metaboliten von Fentanyl und Metaboliten von Fentanyl Analoga
ATE551352T1 (de) Peptidakzeptorbindungsverfahren
DE60223635D1 (de) Reagenzien, Verfahren und Vorrichtungen zum Nachweis von Analyten
ATA8612001A (de) Verfahren zum testen von software
DE60315068D1 (de) Apparat zum unterscheiden von polymorphen von monomorphen tachyarrhythmien
DE60237458D1 (de) Verfahren zum einstecken von seitenteilen mit seitenteilfalz-lokalisationskontrolle
DE60132243D1 (de) Verfahren zum indizieren von entitäten
DE60126337D1 (de) Verfahren zum screenen für gpr40-liganden
DE58905253D1 (de) Verfahren zum verstellen von reibungskupplungen oder -bremsen.
ATE308757T1 (de) Verfahren und kit zur quantifizierung von beta- laktam penizillinen
DE50104426D1 (de) Verfahren zur vernetzung von polyacrylaten
AR042652A1 (es) Bromhidrato de escitalopram y un metodo para su preparacion
EP1305625A4 (de) Verfahren zum immunnachweis von epitopen
DE50115254D1 (de) Verfahren zum erkennen und/oder begrenzen von kurzndler
DK1310763T3 (da) Fremgangsmåde og indretning til detektering af installeringspositionen for en krumtapaksel, og program til detektering af denne installeringsposition
DK0393304T3 (da) Fremgangsmåde til foring af et underjordisk ledningsrør
WO2003027250A3 (en) Monoclonal antibodies to the drug tilmicosin and a method for detecting the same
ATE408832T1 (de) Verfahren zum nachweis von blutzell-antigenen und gegen diese gerichtete antikörper
DE60228927D1 (de) Verfahren und Kit zum Nachweis oder zur Bestimmung von 3,4-Methylendioxymethamphetamin
DE50205213D1 (de) Reibbelagsegment, Reibbelag und Verfahren zu deren Herstellung
DE60129933D1 (de) Verfahren zum screening
DE50101211D1 (de) Abklebewerkzeug und verfahren zum automatisierten, serienmässigen applizieren von klebeband
DE50108185D1 (de) Träger zum tragen von medizinischen apparaten
DE59004890D1 (de) Verfahren zum Bestimmen des Permeationsverhaltens.
EP1312923A3 (de) Verfahren und Kit zum Nachweis, oder zum Quantifizieren von, Metaboliten von Fentanyl und Metaboliten von Fentanyl Analogen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOCKHORNI & KOLLEGEN, 80687 MUENCHEN

8380 Miscellaneous part iii

Free format text: DINGLICHES RECHT WURDE BESTELLT

8380 Miscellaneous part iii

Free format text: DINGLICHES RECHT WURDE BESTELLT